Financial statements Novagen Pharma

Balance sheet of Novagen Pharma

Company age:
Age:
12 y. 4 m. 5 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of NOVAGEN PHARMA

Year
2018
2019
2020
2022
Total assets 2 543 517,36 2 713 735,43 3 000 120,17 2 377 797,58
A. Fixed assets 2 265 152,85 1 960 801,65 1 956 450,45 1 950 000,00
B. Current assets 278 364,51 752 933,78 1 043 669,72 427 797,58
C. Share capital contributions (basic funds) - - - -
D. Own shares (stocks) - - - -
Total liabilities 2 543 517,36 2 713 735,43 3 000 120,17 2 377 797,58
A. Equity -69 491,31 -274 804,29 -240 978,05 -694 358,19
B. Liabilities and provisions for liabilities 2 613 008,67 2 988 539,72 3 241 098,22 3 072 155,77
I. Long-term liabilities 2 590 000,00 2 675 000,00 2 675 000,00 2 675 000,00
II. Short-term liabilities 23 008,67 313 539,72 566 098,22 397 155,77
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.